Table 1.

List of studies evaluating the role of transaminases on outcomes after transarterial chemoembolization.

First Author, Year	N	UninodularDisease (%)	Child–Pugh A (%)	Post-TACE Syndrome (%)	Role of Transaminases
Granito, 2022 [10]	70	61.5%	84.3%	31.4%	AST and/or ALT increase >50% from baseline were independent predictors of complete radiological response
Jia, 2022 [14] and Nam, 2020 [16]	1336	NR	83.6%	NR	The ASARA score, which includes AST, predicts overall survival after TACE
Tang, 2018 [11]	315	20.3%	98.8%	NR	AST-to-platelet ratio predicted radiological response
Zhu, 2018 [12]	351	86.3%	78.6%	NR	AST-to-platelet ratio and ALT predicted disease-free survival
Liu, 2017 [17]	760	41.2%	81.7%	NR	AST-to-ALT ratio predicts overall survival.
Ha, 2016 [15]	153	25.5%	76.5%	NR	The ART score, which includes AST, predicted overall survival
Yang, 2015 [13]	189	58.7%	87.3%	NR	AST-lymphocyte ratio index independently associated with overall survival

AST: aspartate aminotransferase; ALT; alanine aminotransferase; NR: not reported; TACE: Transarterial chemoembolization.